[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]
[FORM 20-F (Mark One) o OR x For the fiscal year ended December 31, 2018. OR o For the transition period from to OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . JD.com, Inc. N/A Cayman Islands (Jurisdiction of Incorporation] [EXCLUSIVE TECHNOLOGY CONSULTIN]
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]
[FORM 20-F (Mark One) o OR x For the fiscal year ended December 31, 2018. OR o For the transition period from to OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . JD.com, Inc. N/A Cayman Islands (Jurisdiction of Incorporation] [EXCLUSIVE TECHNOLOGY CONSULTIN]
[☐ ☐ Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer (Do not check if a smaller reporting company) ☐ Emerging growth company ☒ Smaller reporting company ☐ ☒ The aggregate market value of the voting and non-voting common equity held by non-affiliates as of June 30, 2018 was approxi]
[☐ ☐ Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer (Do not check if a smaller reporting company) ☐ Emerging growth company ☒ Smaller reporting company ☐ ☒ The aggregate market value of the voting and non-voting common equity held by non-affiliates as of June 30, 2018 was approxi]
